Back to Search
Start Over
Fezolinetant: a novel nonhormonal therapy for vasomotor symptoms due to menopause requiring a careful evaluation of the benefit-risk balance.
- Source :
-
Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Oct; Vol. 25 (14), pp. 1971-1972. Date of Electronic Publication: 2024 Sep 29. - Publication Year :
- 2024
- Subjects :
- Humans
Female
Risk Assessment
Menopause
Hot Flashes drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1744-7666
- Volume :
- 25
- Issue :
- 14
- Database :
- MEDLINE
- Journal :
- Expert opinion on pharmacotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 39323314
- Full Text :
- https://doi.org/10.1080/14656566.2024.2410398